| Indoleamine 2, 3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment S Moretti, E Menicali, P Voce, S Morelli, S Cantarelli, M Sponziello, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), E832-E840, 2014 | 78 | 2014 |
| Immune profiling of thyroid carcinomas suggests the existence of two major phenotypes: an ATC-like and a PDTC-like R Giannini, S Moretti, C Ugolini, E Macerola, E Menicali, N Nucci, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3557-3575, 2019 | 53 | 2019 |
| Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma E Menicali, S Moretti, P Voce, S Romagnoli, N Avenia, E Puxeddu Frontiers in endocrinology 3, 67, 2012 | 49 | 2012 |
| Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation S Morelli, G Reboldi, S Moretti, E Menicali, N Avenia, E Puxeddu Endocrine 52, 571-578, 2016 | 34 | 2016 |
| The aryl hydrocarbon receptor is expressed in thyroid carcinoma and appears to mediate epithelial-mesenchymal-transition S Moretti, N Nucci, E Menicali, S Morelli, V Bini, R Colella, M Mandarano, ... Cancers 12 (1), 145, 2020 | 29 | 2020 |
| Immune landscape of thyroid cancers: new insights E Menicali, M Guzzetti, S Morelli, S Moretti, E Puxeddu Frontiers in Endocrinology 11, 637826, 2021 | 26 | 2021 |
| THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedside S Moretti, E Menicali, N Nucci, M Guzzetti, S Morelli, E Puxeddu European Journal of Endocrinology 183 (2), R41-R55, 2020 | 20 | 2020 |
| Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2, 3-dioxygenase 1 S Moretti, E Menicali, N Nucci, P Voce, R Colella, RM Melillo, F Liotti, ... Journal of Biological Chemistry 292 (5), 1785-1797, 2017 | 16 | 2017 |
| Molecular Markers in Thyroid Fine-Needle Aspiration Biopsies MC Zatelli, E Puxeddu, E Menicali, E Uberti, S Filetti Minimally Invasive Therapies for Endocrine Neck Diseases, 37-51, 2016 | | 2016 |
| Indoleamine 2, 3-dioxygenase 1 (IDO1) and thyroid carcinoma: Ret/PTC appears as a strong genetic determinant for IDO1 expression E Menicali, S Moretti, P Voce, R Melillo, M Sponziello, S Filetti, N Avenia, ... Endocrine Abstracts 29, 2012 | | 2012 |
| EFFETTO DI DUE INIBITORI CHINASICI IN LINEE CELLULARI DI CARCINOMA TIROIDEO: STUDI IN VITRO E IN VIVO P Voce, M D’Agostino, S Moretti, E Menicali, N Giusti, N Avenia, ... VI Congresso Associazione Italiana della Tiroide, 2012 | | 2012 |
| OSSERVATORIO REGIONE UMBRIA E Puxeddu, V Bini, E Menicali, S Moretti, S Morelli Monitoraggio della iodoprofilassi in Italia. Dati 2015-2019 21, 106, 0 | | |
